Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld®, Contrary to 8 Prior Main Variant of Concern (VOC)
Céline Boschi, Philippe Colson, Audrey Bancod, Valérie Moal, Bernard La Scola
Abstract
International audience
Topics & Concepts
MedicineMonoclonal antibodyVirologyAntibodyImmunologyInhalation and Respiratory Drug DeliveryInnovative Microfluidic and Catalytic Techniques InnovationBiosimilars and Bioanalytical Methods